Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones.

Martin Bråbäck; Kristian Riesbeck; Arne Forsgren

doi:10.1128/AAC.46.4.1114–1116.2002

Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones.

Martin Bråbäck, Kristian Riesbeck, Arne Forsgren

Research output: Contribution to journal › Article › peer-review

204 Downloads (Pure)

Abstract

The susceptibility pattern of Mycobacterium marinum was determined. Quinupristin-dalfopristin and telithromycin were less active than clarithromycin. Linezolid showed good antimicrobial activity at clinically achievable concentrations. Gatifloxacin, levofloxacin, and moxifloxacin displayed activities similar to those of ciprofloxacin. Gemifloxacin was less active. The Etest method showed variable agreement with the reference method.

Original language	English
Pages (from-to)	1114-1116
Journal	Antimicrobial Agents and Chemotherapy
Volume	46
Issue number	4
DOIs	https://doi.org/10.1128/AAC.46.4.1114–1116.2002
Publication status	Published - 2002

Subject classification (UKÄ)

Microbiology in the medical area

Access to Document

10.1128/AAC.46.4.1114–1116.2002

1114

http://aac.asm.org/cgi/reprint/46/4/1114.pdf

Fingerprint

Dive into the research topics of 'Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones.'. Together they form a unique fingerprint.

Cite this

Bråbäck, M., Riesbeck, K., & Forsgren, A. (2002). Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones. Antimicrobial Agents and Chemotherapy, 46(4), 1114-1116. https://doi.org/10.1128/AAC.46.4.1114–1116.2002

Bråbäck, Martin ; Riesbeck, Kristian ; Forsgren, Arne. / Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones. In: Antimicrobial Agents and Chemotherapy. 2002 ; Vol. 46, No. 4. pp. 1114-1116.

@article{91c442afe61146da95b23ab49959e688,

title = "Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones.",

abstract = "The susceptibility pattern of Mycobacterium marinum was determined. Quinupristin-dalfopristin and telithromycin were less active than clarithromycin. Linezolid showed good antimicrobial activity at clinically achievable concentrations. Gatifloxacin, levofloxacin, and moxifloxacin displayed activities similar to those of ciprofloxacin. Gemifloxacin was less active. The Etest method showed variable agreement with the reference method.",

author = "Martin Br{\aa}b{\"a}ck and Kristian Riesbeck and Arne Forsgren",

year = "2002",

doi = "10.1128/AAC.46.4.1114–1116.2002",

language = "English",

volume = "46",

pages = "1114--1116",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "1098-6596",

publisher = "American Society for Microbiology",

number = "4",

}

Bråbäck, M , Riesbeck, K & Forsgren, A 2002, 'Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones.', Antimicrobial Agents and Chemotherapy, vol. 46, no. 4, pp. 1114-1116. https://doi.org/10.1128/AAC.46.4.1114–1116.2002

Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones. / Bråbäck, Martin ; Riesbeck, Kristian; Forsgren, Arne.
In: Antimicrobial Agents and Chemotherapy, Vol. 46, No. 4, 2002, p. 1114-1116.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones.

AU - Bråbäck, Martin

AU - Riesbeck, Kristian

AU - Forsgren, Arne

PY - 2002

Y1 - 2002

N2 - The susceptibility pattern of Mycobacterium marinum was determined. Quinupristin-dalfopristin and telithromycin were less active than clarithromycin. Linezolid showed good antimicrobial activity at clinically achievable concentrations. Gatifloxacin, levofloxacin, and moxifloxacin displayed activities similar to those of ciprofloxacin. Gemifloxacin was less active. The Etest method showed variable agreement with the reference method.

AB - The susceptibility pattern of Mycobacterium marinum was determined. Quinupristin-dalfopristin and telithromycin were less active than clarithromycin. Linezolid showed good antimicrobial activity at clinically achievable concentrations. Gatifloxacin, levofloxacin, and moxifloxacin displayed activities similar to those of ciprofloxacin. Gemifloxacin was less active. The Etest method showed variable agreement with the reference method.

U2 - 10.1128/AAC.46.4.1114–1116.2002

DO - 10.1128/AAC.46.4.1114–1116.2002

M3 - Article

SN - 1098-6596

VL - 46

SP - 1114

EP - 1116

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 4

ER -

Bråbäck M , Riesbeck K, Forsgren A. Susceptibilities of Mycobacterium marinum to Gatifloxacin, Gemifloxacin, Levofloxacin, Linezolid, Moxifloxacin, Telithromycin, and Quinupristin-Dalfopristin (Synercid) Compared to Its Susceptibilities to Reference Macrolides and Quinolones. Antimicrobial Agents and Chemotherapy. 2002;46(4):1114-1116. doi: 10.1128/AAC.46.4.1114–1116.2002